246 related articles for article (PubMed ID: 11935269)
1. Alpha-synuclein-immunoreactive deposits in human and animal prion diseases.
Haïk S; Privat N; Adjou KT; Sazdovitch V; Dormont D; Duyckaerts C; Hauw JJ
Acta Neuropathol; 2002 May; 103(5):516-20. PubMed ID: 11935269
[TBL] [Abstract][Full Text] [Related]
2. Quantification of surviving cerebellar granule neurones and abnormal prion protein (PrPSc) deposition in sporadic Creutzfeldt-Jakob disease supports a pathogenic role for small PrPSc deposits common to the various molecular subtypes.
Faucheux BA; Morain E; Diouron V; Brandel JP; Salomon D; Sazdovitch V; Privat N; Laplanche JL; Hauw JJ; Haïk S
Neuropathol Appl Neurobiol; 2011 Aug; 37(5):500-12. PubMed ID: 21450052
[TBL] [Abstract][Full Text] [Related]
3. Loss of cerebellar granule neurons is associated with punctate but not with large focal deposits of prion protein in Creutzfeldt-Jakob disease.
Faucheux BA; Privat N; Brandel JP; Sazdovitch V; Laplanche JL; Maurage CA; Hauw JJ; Haïk S
J Neuropathol Exp Neurol; 2009 Aug; 68(8):892-901. PubMed ID: 19606064
[TBL] [Abstract][Full Text] [Related]
4. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
[TBL] [Abstract][Full Text] [Related]
5. Abnormal synaptic protein expression and cell death in murine scrapie.
Sisó S; Puig B; Varea R; Vidal E; Acín C; Prinz M; Montrasio F; Badiola J; Aguzzi A; Pumarola M; Ferrer I
Acta Neuropathol; 2002 Jun; 103(6):615-26. PubMed ID: 12012094
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein deficiency in the C57BL/6JOlaHsd strain does not modify disease progression in the ME7-model of prion disease.
Asuni AA; Hilton K; Siskova Z; Lunnon K; Reynolds R; Perry VH; O'Connor V
Neuroscience; 2010 Feb; 165(3):662-74. PubMed ID: 19879926
[TBL] [Abstract][Full Text] [Related]
7. The epsilon isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Sträussler-Scheinker disease.
Di Fede G; Giaccone G; Limido L; Mangieri M; Suardi S; Puoti G; Morbin M; Mazzoleni G; Ghetti B; Tagliavini F
J Neuropathol Exp Neurol; 2007 Feb; 66(2):124-30. PubMed ID: 17278997
[TBL] [Abstract][Full Text] [Related]
8. Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture.
Lawson VA; Vella LJ; Stewart JD; Sharples RA; Klemm H; Machalek DM; Masters CL; Cappai R; Collins SJ; Hill AF
Int J Biochem Cell Biol; 2008; 40(12):2793-801. PubMed ID: 18590830
[TBL] [Abstract][Full Text] [Related]
9. Pathologic prion protein spreading in the peripheral nervous system of a patient with sporadic Creutzfeldt-Jakob disease.
Favereaux A; Quadrio I; Vital C; Perret-Liaudet A; Anne O; Laplanche JL; Petry KG; Vital A
Arch Neurol; 2004 May; 61(5):747-50. PubMed ID: 15148153
[TBL] [Abstract][Full Text] [Related]
10. Differential expression and protein distribution of Bax in natural scrapie.
Lyahyai J; Bolea R; Serrano C; Vidal E; Pumarola M; Badiola JJ; Zaragoza P; Martín-Burriel I
Brain Res; 2007 Nov; 1180():111-20. PubMed ID: 17949698
[TBL] [Abstract][Full Text] [Related]
11. Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease.
Schoch G; Seeger H; Bogousslavsky J; Tolnay M; Janzer RC; Aguzzi A; Glatzel M
PLoS Med; 2006 Feb; 3(2):e14. PubMed ID: 16354106
[TBL] [Abstract][Full Text] [Related]
12. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie.
Snow AD; Wight TN; Nochlin D; Koike Y; Kimata K; DeArmond SJ; Prusiner SB
Lab Invest; 1990 Nov; 63(5):601-11. PubMed ID: 1977959
[TBL] [Abstract][Full Text] [Related]
13. Prion proteins: physiological functions and role in neurological disorders.
Hu W; Kieseier B; Frohman E; Eagar TN; Rosenberg RN; Hartung HP; Stüve O
J Neurol Sci; 2008 Jan; 264(1-2):1-8. PubMed ID: 17707411
[TBL] [Abstract][Full Text] [Related]
14. The metabolism of glycosaminoglycans is impaired in prion diseases.
Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
[TBL] [Abstract][Full Text] [Related]
15. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle.
Kovacs GG; Lindeck-Pozza E; Chimelli L; Araújo AQ; Gabbai AA; Ströbel T; Glatzel M; Aguzzi A; Budka H
Ann Neurol; 2004 Jan; 55(1):121-5. PubMed ID: 14705121
[TBL] [Abstract][Full Text] [Related]
16. Different prion conformers target the olfactory pathway in sporadic Creutzfeldt-Jakob disease.
Zanusso G; Ferrari S; Benedetti D; Sbriccoli M; Rizzuto N; Monaco S
Ann N Y Acad Sci; 2009 Jul; 1170():637-43. PubMed ID: 19686205
[TBL] [Abstract][Full Text] [Related]
17. Disease-associated prion protein in vessel walls.
Koperek O; Kovács GG; Ritchie D; Ironside JW; Budka H; Wick G
Am J Pathol; 2002 Dec; 161(6):1979-84. PubMed ID: 12466112
[TBL] [Abstract][Full Text] [Related]
18. Prion protein glycosylation.
Lawson VA; Collins SJ; Masters CL; Hill AF
J Neurochem; 2005 May; 93(4):793-801. PubMed ID: 15857383
[TBL] [Abstract][Full Text] [Related]
19. Redox metals and oxidative abnormalities in human prion diseases.
Petersen RB; Siedlak SL; Lee HG; Kim YS; Nunomura A; Tagliavini F; Ghetti B; Cras P; Moreira PI; Castellani RJ; Guentchev M; Budka H; Ironside JW; Gambetti P; Smith MA; Perry G
Acta Neuropathol; 2005 Sep; 110(3):232-8. PubMed ID: 16096758
[TBL] [Abstract][Full Text] [Related]
20. Variant Creutzfeldt-Jakob disease: immunocytochemical studies and image analysis.
Nailon WH; Ironside JW
Microsc Res Tech; 2000 Jul; 50(1):2-9. PubMed ID: 10871542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
